{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T16:40:01Z","timestamp":1746376801643,"version":"3.40.4"},"reference-count":39,"publisher":"APO Society of Specialists in Heart Failure","issue":"4S","license":[{"start":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T00:00:00Z","timestamp":1558656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/lib.ossn.ru\/jour\/about\/editorialPolicies#openAccessPolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kardiologiia"],"abstract":"<jats:p>We present a 13-years follow-up results in patient with dilated cardiomyopathy. We performed intracoronary infusion of bone marrow mononuclear fraction in patient with 4th heart failure functional class in 2005. We observed an improvement in symptoms (patient had 1st functional class of heart failure) during 10-years follow-up. In 2015 due to clinical worsening we performed 2nd and 3rd bone marrow mononuclear cells infusion with 9-month interval. We observed a signifcant improvement in symptoms, EF and LV sizes. We continue the follow-up.<\/jats:p>","DOI":"10.18087\/cardio.2555","type":"journal-article","created":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T09:47:07Z","timestamp":1558950427000},"page":"59-64","source":"Crossref","is-referenced-by-count":1,"title":["Cell therapy in the multimodality treatment of a patient with dilated cardiomyopathy. A case report"],"prefix":"10.18087","volume":"59","author":[{"given":"S. A.","family":"Beliy","sequence":"first","affiliation":[{"name":"Academician Pavlov First St. Petersburg State Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. I.","family":"Lukashenko","sequence":"additional","affiliation":[{"name":"Academician Pavlov First St. Petersburg State Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. V.","family":"Komok","sequence":"additional","affiliation":[{"name":"Academician Pavlov First St. Petersburg State Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. G.","family":"Khubulava","sequence":"additional","affiliation":[{"name":"Academician Pavlov First St. Petersburg State Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7442","published-online":{"date-parts":[[2019,5,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Braunwald E. Cardiomyopathies: An Overview. Circulation Research. 2017;121(7):711\u201321. DOI: 10.1161\/CIRCRESAHA.117.311812","DOI":"10.1161\/CIRCRESAHA.117.311812"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Maron BJ. Contemporary Defnitions and Classifcation of the Cardiomyopathies: An American Heart Association Scientifc Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Commitee, Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups, and Council on Epidemiology and Prevention. Circulation. 2006;113(14):1807\u201316. DOI: 10.1161\/CIRCULATIONAHA.106.174287","DOI":"10.1161\/CIRCULATIONAHA.106.174287"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Report of the 1995 World Health Organization\/International Society and Federation of Cardiology Task Force on the Defnition and Classifcation of Cardiomyopathies. Circulation. 1996;93(5):841\u20132. DOI: 10.1161\/01.CIR.93.5.841","DOI":"10.1161\/01.CIR.93.5.841"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"McKenna WJ, Maron BJ, Tiene G. Classifcation, Epidemiology, and Global Burden of Cardiomyopathies. Circulation Research. 2017;121(7):722\u201330. DOI: 10.1161\/CIRCRESAHA.117.309711","DOI":"10.1161\/CIRCRESAHA.117.309711"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Merlo M, Stolfo D, Anzini M, Negri F, Pinamonti B, Barbati G et al. Persistent recovery of normal lef ventricular function and dimension in idiopathic dilated cardiomyopathy during long\u2010term follow\u2010up: does real healing exist? Journal of the American Heart Association. 2015;4(1):e001504. DOI: 10.1161\/JAHA.114.000570","DOI":"10.1161\/JAHA.114.000570"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Moon J, Shim CY, Kim Y-J, Park S, Kang S-M, Chung N et al. Lef Atrial Volume as a Predictor of Lef Ventricular Functional Recovery in Patients with Dilated Cardiomyopathy and Absence of Delayed Enhancement in Cardiac Magnetic Resonance. Journal of Cardiac Failure. 2016;22(4):265\u201371. DOI: 10.1016\/j.cardfail.2015.12.011","DOI":"10.1016\/j.cardfail.2015.12.011"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Matsumura Y, Hoshikawa-Nagai E, Kubo T, Yamasaki N, Kitaoka H, Takata J et al. Prediction of lef ventricular reverse remodeling afer therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and \u03b2 blockers in patients with idiopathic dilated cardiomyopathy. Cardiovascular Ultrasound. 2015;13(1):14. DOI: 10.1186\/s12947-015-0009-4","DOI":"10.1186\/s12947-015-0009-4"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"McNamara DM, Starling RC, Cooper LT, Boehmer JP, Mather PJ, Janosko KM et al. Clinical and Demographic Predictors of Outcomes in Recent Onset Dilated Cardiomyopathy. Journal of the American College of Cardiology. 2011;58(11):1112\u20138. DOI: 10.1016\/j.jacc.2011.05.033","DOI":"10.1016\/j.jacc.2011.05.033"},{"key":"ref9","unstructured":"Di Lenarda A, Pinamonti B, Mestroni L, Salvi A, Sabbadini G, Gregori D et al. Te natural history of dilated cardiomyopathy: a review of the Heart Muscle Disease Registry of Trieste. Italian Heart Journal. Supplement: Ofcial Journal of the Italian Federation of Cardiology. 2004;5(4):253\u201366. PMID: 15346692"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Merlo M, Cai\ufb00a T, Gobbo M, Adamo L, Sinagra G. Reverse remodeling in Dilated Cardiomyopathy: Insights and future perspectives. IJC Heart & Vasculature. 2018;18:52\u20137. DOI: 10.1016\/j.ijcha.2018.02.005","DOI":"10.1016\/j.ijcha.2018.02.005"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Martin-Rendon E. Meta-Analyses of Human Cell-Based Cardiac Regeneration TerapiesResponse to Martin-Rendon: What Can Systematic Reviews Tell Us About Cell Terapies for Ischemic Heart Disease? Circulation Research. 2016;118(8):1264\u201372. DOI: 10.1161\/CIRCRESAHA.115.307540","DOI":"10.1161\/CIRCRESAHA.115.307540"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Fisher SA, Doree C, Mathur A, Martin-Rendon E. Meta-Analysis of Cell Terapy Trials for Patients with Heart Failure. Circulation Research. 2015;116(8):1361\u201377. DOI: 10.1161\/CIRCRESAHA.116.304386","DOI":"10.1161\/CIRCRESAHA.116.304386"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Fisher SA, Doree C, Mathur A, Taggart DP, Martin-Rendon E. Stem cell therapy for chronic ischaemic heart disease and congestive heart failure. Cochrane Database of Systematic Reviews. 2016, DOI: 10.1002\/14651858.CD007888.pub3","DOI":"10.1002\/14651858.CD007888.pub3"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Beliy S. A., Komok V. V. Cell therapy of chronic heart failure: State of the art. Kardiologiia. 2018,58 (S4):46\u201354. [Russian]. DOI: 10.18087\/cardio.2442","DOI":"10.18087\/cardio.2442"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Caforio ALP, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. European Heart Journal. 2013;34(33):2636\u2013 48. DOI: 10.1093\/eurheartj\/eht210","DOI":"10.1093\/eurheartj\/eht210"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Krejci J, Mlejnek D, Sochorova D, Nemec P. In\ufb02ammatory Cardiomyopathy: A Current View on the Pathophysiology, Diagnosis, and Treatment. BioMed Research International. 2016;2016:4087632. DOI: 10.1155\/2016\/4087632","DOI":"10.1155\/2016\/4087632"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-Trujillo L, V\u00e1zquez-Garza E, Castillo EC, Garc\u00eda-Rivas G, Torre-Amione G. Role of Adaptive Immunity in the Development and Progression of Heart Failure: New Evidence. Archives of Medical Research. 2017;48(1):1\u201311. DOI: 10.1016\/j.arcmed.2016.12.008","DOI":"10.1016\/j.arcmed.2016.12.008"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Ismahil MA, Hamid T, Bansal SS, Patel B, Kingery JR, Prabhu SD. Remodeling of the Mononuclear Phagocyte Network Underlies Chronic In\ufb02ammation and Disease Progression in Heart Failure: Critical Importance of the Cardiosplenic Axis. Circulation Research. 2014;114(2):266\u201382. DOI: 10.1161\/CIRCRESAHA.113.301720","DOI":"10.1161\/CIRCRESAHA.113.301720"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Van Linthout S, Tsch\u00f6pe C. In\ufb02ammation \u2013 Cause or Consequence of Heart Failure or Both? Current Heart Failure Reports. 2017;14(4):251\u201365. DOI: 10.1007\/s11897-017-0337-9","DOI":"10.1007\/s11897-017-0337-9"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Rock KL, Lai J-J, Kono H. Innate and adaptive immune responses to cell death: Immunological reaction to cell death. Immunological Reviews. 2011;243(1):191\u2013205. DOI: 10.1111\/j.1600-065X.2011.01040.x","DOI":"10.1111\/j.1600-065X.2011.01040.x"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Bolli R. Repeated Cell Terapy: A Paradigm Shif Whose Time Has Come. Circulation Research. 2017;120(7):1072\u20134. DOI: 10.1161\/CIRCRESAHA.117.310710","DOI":"10.1161\/CIRCRESAHA.117.310710"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Tokita Y, Tang X\u2013L, Li Q, Wysoczynski M, Hong KU, Nakamura S et al. Repeated Administrations of Cardiac Progenitor Cells Are Markedly More E\ufb00ective Tan a Single Administration: A New Paradigm in Cell Terapy. Circulation Research. 2016;119(5):635\u2013 51. DOI: 10.1161\/CIRCRESAHA.116.308937","DOI":"10.1161\/CIRCRESAHA.116.308937"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Guo Y, Wysoczynski M, Nong Y, Tomlin A, Zhu X, Gumpert AM et al. Repeated doses of cardiac mesenchymal cells are therapeutically superior to a single dose in mice with old myocardial infarction. Basic Research in Cardiology. 2017;112(2):18. DOI: 10.1007\/s00395-017-0606-5","DOI":"10.1007\/s00395-017-0606-5"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Tang X, Nakamura S, Li Q, Wysoczynski M, Gumpert AM, Wu W et al. Repeated Administrations of Cardiac Progenitor Cells Are Superior to a Single Administration of an Equivalent Cumulative Dose. Journal of the American Heart Association. 2018;7(4):pii: e007400. DOI: 10.1161\/JAHA.117.007400","DOI":"10.1161\/JAHA.117.007400"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Wysoczynki M, Khan A, Bolli R. New Paradigms in Cell Terapy: Repeated Dosing, Intravenous Delivery, Immunomodulatory Actions, and New Cell Types. Circulation Research. 2018;123(2): 138\u201358. DOI: 10.1161\/CIRCRESAHA.118.313251","DOI":"10.1161\/CIRCRESAHA.118.313251"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Kubal C, Sheth K, Nadal-Ginard B, Gali\u00f1anes M. Bone marrow cells have a potent anti-ischemic e\ufb00ect against myocardial cell death in humans. Te Journal of Toracic and Cardiovascular Surgery. 2006;132(5):1112\u20138. DOI: 10.1016\/j.jtcvs.2006.06.028","DOI":"10.1016\/j.jtcvs.2006.06.028"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Duran JM, Makarewich CA, Sharp TE, Starosta T, Zhu F, Ho\ufb00man NE et al. Bone-Derived Stem Cells Repair the Heart Afer Myocardial Infarction Trough Transdi\ufb00erentiation and Paracrine Signaling Mechanisms. Circulation Research. 2013;113(5):539\u2013 52. DOI: 10.1161\/CIRCRESAHA.113.301202","DOI":"10.1161\/CIRCRESAHA.113.301202"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Hodgkinson CP, Bareja A, Gomez JA, Dzau VJ. Emerging Concepts in Paracrine Mechanisms in Regenerative Cardiovascular Medicine and Biology. Circulation Research. 2016;118(1):95\u2013107. DOI: 10.1161\/CIRCRESAHA.115.305373","DOI":"10.1161\/CIRCRESAHA.115.305373"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Karantalis V, Balkan W, Schulman IH, Hatzistergos KE, Hare JM. Cell-based therapy for prevention and reversal of myocardial remodeling. American Journal of Physiology-Heart and Circulatory Physiology. 2012;303(3):H256\u201370. DOI: 10.1152\/ajpheart.00221.2012","DOI":"10.1152\/ajpheart.00221.2012"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Alestalo K, Mietinen JA, Vuolteenaho O, Huikuri H, Lehenkari P. Bone Marrow Mononuclear Cell Transplantation Restores In\ufb02ammatory Balance of Cytokines afer ST Segment Elevation Myocardial Infarction. PLOS ONE. 2015;10(12): e0145094. DOI: 10.1371\/journal.pone.0145094","DOI":"10.1371\/journal.pone.0145094"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Barile L, Cerisoli F, Frati G, Gaetani R, Chimenti I, Forte E et al. Bone marrow-derived cells can acquire cardiac stem cells properties in damaged heart. Journal of Cellular and Molecular Medicine. 2011;15(1):63\u201371. DOI: 10.1111\/j.1582-4934.2009.00968.x","DOI":"10.1111\/j.1582-4934.2009.00968.x"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Yoon C-H, Koyanagi M, Iekushi K, Seeger F, Urbich C, Zeiher AM et al. Mechanism of Improved Cardiac Function Afer Bone Marrow Mononuclear Cell Terapy: Role of Cardiovascular Lineage Commitment. Circulation. 2010;121(18):2001\u201311. DOI: 10.1161\/CIRCULATIONAHA.109.909291","DOI":"10.1161\/CIRCULATIONAHA.109.909291"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Van den Akker F, Deddens JC, Doevendans PA, Sluijter JPG. Cardiac stem cell therapy to modulate in\ufb02ammation upon myocardial infarction. Biochimica et Biophysica Acta (BBA) \u2013 General Subjects. 2013;1830(2):2449\u201358. DOI: 10.1016\/j.bbagen.2012.08.026","DOI":"10.1016\/j.bbagen.2012.08.026"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Marguti I, Yamamoto GL, da Costa TB, Rizzo LV, de Moraes LV. Expansion of CD4+ CD25+ Foxp3+ T cells by bone marrowderived dendritic cells: In vitro Treg expansion by dendritic cells. Immunology. 2009;127(1):50\u201361. DOI: 10.1111\/j.1365-2567.2008.02927.x","DOI":"10.1111\/j.1365-2567.2008.02927.x"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Chen B, Frangogiannis NG. Immune cells in repair of the infarcted myocardium. Microcirculation. 2017;24(1):e12305. DOI: 10.1111\/micc.12305","DOI":"10.1111\/micc.12305"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Lu Y, Wang Y, Lin M, Zhou J, Wang Z, Jiang M et al. A systematic review of randomised controlled trials examining the therapeutic e\ufb00ects of adult bone marrow-derived stem cells for non-ischaemic dilated cardiomyopathy. Stem Cell Research & Terapy. 2016;7(1):186. DOI: 10.1186\/s13287-016-0441-x","DOI":"10.1186\/s13287-016-0441-x"},{"key":"ref37","unstructured":"Jiao R, Liu Y, Yang W-J, Zhu X-Y, Li J, Tang Q-Z. E\ufb00ects of stem cell therapy on dilated cardiomyopathy. Saudi Medical Journal. 2014;35(12):1463\u20138. PMID: 25491210"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Marquis-Gravel G, Stevens L\u2013M, Mansour S, Avram R, Noiseux N. Stem Cell Terapy for the Treatment of Nonischemic Cardiomyopathy: A Systematic Review of the Literature and Meta-analysis of Randomized Controlled Trials. Canadian Journal of Cardiology. 2014;30(11):1378\u201384. DOI: 10.1016\/j.cjca.2014.03.026","DOI":"10.1016\/j.cjca.2014.03.026"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Poglajen G, Zemlji\u010d G, Frljak S, Cerar A, Andro\u010dec V, Sever M et al. Stem Cell Terapy in Patients with Chronic Nonischemic Heart Failure. Stem Cells International. 2018;2018:6487812. DOI: 10.1155\/2018\/6487812","DOI":"10.1155\/2018\/6487812"}],"container-title":["Kardiologiia"],"original-title":[],"link":[{"URL":"https:\/\/lib.ossn.ru\/jour\/article\/viewFile\/649\/418","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T16:02:35Z","timestamp":1746374555000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardio.elpub.ru\/jour\/article\/view\/649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,24]]},"references-count":39,"journal-issue":{"issue":"4S","published-online":{"date-parts":[[2019,5,24]]}},"URL":"https:\/\/doi.org\/10.18087\/cardio.2555","relation":{},"ISSN":["2412-5660","0022-9040"],"issn-type":[{"type":"electronic","value":"2412-5660"},{"type":"print","value":"0022-9040"}],"subject":[],"published":{"date-parts":[[2019,5,24]]}}}